Drug Shortage Report for FUROSEMIDE INJECTION SDZ
Report ID | 38763 |
Drug Identification Number | 02382539 |
Brand name | FUROSEMIDE INJECTION SDZ |
Common or Proper name | FUROSEMIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | FUROSEMIDE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 X 2 ML AMPOULES |
ATC code | C03CA |
ATC description | HIGH-CEILING DIURETICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-01-29 |
Estimated end date | 2018-03-02 |
Actual end date | 2018-03-13 |
Shortage status | Resolved |
Updated date | 2018-03-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-03-23 | French | Compare |
v5 | 2018-03-23 | English | Compare |
v4 | 2018-02-15 | French | Compare |
v3 | 2018-02-15 | English | Compare |
v2 | 2018-02-05 | French | Compare |
v1 | 2018-02-05 | English | Compare |
Showing 1 to 6 of 6